ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Condition: Retinoblastoma
Gene/Gene Panel: RB1
Context: Pediatric
Date
Status
Outcomes-Interventions
Notes
2022/02/09
Released
1.3.4
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Internal system migration associated with MONDO name addition.
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
RB1 0008380 RETINOBLASTOMA; RB1
Strong Actionability
Strong Actionability
2022/02/09
Released (Under revision)
1.3.3
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
RB1 0008380 RETINOBLASTOMA; RB1
Strong Actionability
Strong Actionability
2022/01/19
Released
1.3.3
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Assertions
Gene Condition Pairs
Suggested Assertion
Final Assertion
RB1 0008380 RETINOBLASTOMA; RB1
Strong Actionability
Strong Actionability
2021/10/18
Released (Under revision)
1.3.2
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Revisions made to the early rule-out form (which covers material in both pediatric and adult contexts). Updates to the early rule-out only applies to the adult report.
2021/09/15
Released
1.3.2
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Revisions made to the early rule-out form (which covers material in both pediatric and adult contexts). Updates to the early rule-out only applies to the adult report.
2021/09/15
Released (Under revision)
1.3.1
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
MONDO IDs added, scoring groups unadjusted.
2020/12/23
Released
1.3.1
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
MONDO IDs added, scoring groups unadjusted.
2020/04/22
Released (Under revision)
1.3.0
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/10/03
Released
1.3.0
Morbidity or mortality from retinoblastoma (GroupA)
Surveillance (GroupA) 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms (GroupA)
Surveillance (GroupA) 9CN
Internal system migration associated with Gene-Disease scoring groups upgrades.
2019/06/13
Released
1.2.1
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CN
2019/06/13
Released (Under revision)
1.2.0
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CN
Internal system migration related to merging adult and pediatric contexts.
2019/04/04
Released
1.2.0
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CN
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.1.1
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CN
Internal system migration related to score text replacement from E to N
2018/08/15
Released
1.1.0
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CE
2018/08/15
Released (Under revision)
1.0.1
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CE
2018/08/10
Released
1.0.1
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CE
2018/08/10
Released (Under revision)
1.0.0
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CE
2018/07/19
Released
1.0.0
Morbidity or mortality from retinoblastoma
Surveillance 10CB
Morbidity or mortality from second extra-ocular malignant neoplasms
Surveillance 9CE
2018/06/11
In Preparation
N/A
¤ Powered by BCM's Genboree.